EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Racial/ethnic disparities in curative‐intent treatment for early‐stage non‐small cell lung cancer patients among heterogeneous Black populations: US ‐born Black, Afro‐Haitian, West Indian Black, and Hispanic Black

Kamaria T Jacobs, Qinran Liu iD, Clyde P Brown, Gilberto Lopes, Paulo S Pinheiro

Cancer Medicine · 2024

DOI: 10.1002/cam4.7449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Kamaria T Jacobs und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, Florida, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Healthcare Disparities, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bankhead-Coley Cancer Biomedical Research Program of the State of Florida.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heterogeneous Black populations encounter significant obstacles in accessing cancer care, yet research on lung cancer treatment disparities remains limited. This study investigates whether the disparity in receiving curative‐intent treatment (curative‐intent surgery and/or stereotactic body radiation therapy [SBRT]) for early‐stage non‐small cell lung cancer (NSCLC) between non‐Hispanic Whites (NHWs) and total Blacks extends to diverse Black populations, including US‐born, Afro‐Haitian, West Indian Black, and Hispanic Black individuals.

Methods

This cross‐sectional study included all Florida cancer registry early‐stage NSCLC cases 2005–2017, linked to individual‐level discharge data containing comorbidity and specific treatment details (surgery and/or SBRT). Multivariable logistic regression assessed the association between race/ethnicity and the receipt of curative‐intent treatment, while accounting for sociodemographic factors (poverty, age, insurance, and smoking status) and clinical variables.

Results

Among 55,655 early‐stage NSCLC patients, 71.1% received curative‐intent treatment: 72.1% NHW and 59.7% Black (non‐Hispanic and Hispanic) individuals. Black patients had 35% lower odds (OR adj , 0.65; 95% CI, 0.59–0.70) of receiving curative‐intent treatment compared to NHW patients. ORs varied from 0.57 (95% CI, 0.59–0.70) for Hispanic Black to 0.76 (95% CI, 0.56–1.02) for West Indian Black. Remarkably, Black‐White disparities persisted despite the availability of curative treatment options (SBRT) for both high Charlson Comorbidity Index (CCI) observed among US‐born Blacks and surgery for low CCI patients among all other Black subgroups.

Conclusions

Pronounced disparities in accessing curative‐intent treatments for early‐stage NSCLC were evident across all Black subgroups, regardless of treatment availability and comorbidity profile. These findings underscore the need to address Black heterogeneity and prompt further research to rectify treatment disparities in early‐stage NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungHealthcare DisparitiesLung NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedBlack or African AmericanCross-Sectional StudiesFloridaHispanic or LatinoNeoplasm StagingCaribbean People

Stichwörter der Autor:innen

African AmericanBlack HispanicsBlack subgroupsComorbiditiesCurative‐intent treatmentHaitiansLung cancerRacial disparitiesStereotactic body radiation therapySurgeryTreatment disparitiesUS‐born BlacksWest Indians

Autor:innen und Institutionen

  • College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, Tallahassee, Florida, USA.
  • Department of Public Health Sciences, University of Miami School of Medicine, Miami, Florida, USA.
  • Department of Surveillance and Health Equity Science, American Cancer Society, Atlanta, Georgia, USA.
  • Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA.

ORCID-Profile: Qinran Liu

Förderung

  • Bankhead-Coley Cancer Biomedical Research Program of the State of Florida

Zitieren

APA

Jacobs, K. T., Liu, Q., Brown, C. P., Lopes, G., & Pinheiro, P. S. (2024). Racial/ethnic disparities in curative‐intent treatment for early‐stage non‐small cell lung cancer patients among heterogeneous Black populations: US ‐born Black, Afro‐Haitian, West Indian Black, and Hispanic Black. Cancer Medicine. https://doi.org/10.1002/cam4.7449

Vancouver

Jacobs KT, Liu Q, Brown CP, Lopes G, Pinheiro PS. Racial/ethnic disparities in curative‐intent treatment for early‐stage non‐small cell lung cancer patients among heterogeneous Black populations: US ‐born Black, Afro‐Haitian, West Indian Black, and Hispanic Black. Cancer Medicine. 2024. doi:10.1002/cam4.7449

BibTeX
@article{Jacobs2024,
  author = {Jacobs, Kamaria T and Liu, Qinran and Brown, Clyde P and Lopes, Gilberto and Pinheiro, Paulo S},
  title = {Racial/ethnic disparities in curative‐intent treatment for early‐stage non‐small cell lung cancer patients among heterogeneous Black populations: US ‐born Black, Afro‐Haitian, West Indian Black, and Hispanic Black},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7449}
}
Kostenlos starten →